First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies

Jordan Berlin, Anthony W. Tolcher, Cliff Ding, Jennifer G. Whisenant, Ivan D. Horak, Debra L. Wood, Paul I. Nadler, Ulla H. Hansen, Johan Lantto, Niels Jørgen Østergaard Skartved, Mikkel W. Pedersen, Amita Patnaik